- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01470768
Evaluation of Fatty Acid Levels and Growth in Infants Fed Amino Acid Based (AA) Formulas
March 20, 2012 updated by: Mead Johnson Nutrition
Evaluation of Fatty Acid Levels and Growth in Infants Fed Amino Acid Based Formulas
This clinical trial will compare the amount of fatty acids in whole blood of babies fed one of two study formulas for 4 months.
Study Overview
Status
Withdrawn
Conditions
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
United Kingdon
-
London, United Kingdon, United Kingdom, WC1N1EH
- Great Ormand Street Hospital and Institute of Child Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 6 months (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 0 to 6 months of age inclusive
- Born at ≥ 37 weeks gestation
- Birth weight of 2500 g (5 lb 8 oz) or more
- Infants suspected to be cow's milk allergic and who do not tolerate extensively hydrolyzed formula OR infants intolerant to breast milk
- Infants with symptoms suggestive of cow's milk allergy
- Signed Informed Consent
Exclusion Criteria:
- Infants who for whatever reasons were not discharged home as per routine
- Infants with metabolic illness requiring a special formula
- Infants fed with nasogastric tube
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Arm 1 - AA Formula with DHA and ARA
Marketed AA formula with Docosahexanoic Acid (DHA) and Arachidonic Acid (ARA)
|
|
Other: Arm 2 - AA Formula with alternative levels of DHA and ARA
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Level of fatty acids in whole blood of infants
Time Frame: 4 months
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
body weight
Time Frame: 4 months
|
4 months
|
Occurrence of allergic manifestations
Time Frame: 4 months
|
4 months
|
Occurrence of adverse events
Time Frame: 4 months
|
4 months
|
Incidence of gas
Time Frame: 4 months
|
4 months
|
Incidence of fussiness
Time Frame: 4 months
|
4 months
|
Stool characteristics
Time Frame: 4 months
|
4 months
|
Body length
Time Frame: 4 months
|
4 months
|
Head Circumference
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nikhil Thapar, M.D., UCL Institute of Child Health and Great Ormond Street Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Anticipated)
December 1, 2013
Study Completion (Anticipated)
December 1, 2013
Study Registration Dates
First Submitted
October 26, 2011
First Submitted That Met QC Criteria
November 10, 2011
First Posted (Estimate)
November 11, 2011
Study Record Updates
Last Update Posted (Estimate)
March 22, 2012
Last Update Submitted That Met QC Criteria
March 20, 2012
Last Verified
March 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cow's Milk Allergy
-
University of Campinas, BrazilCompleted
-
Edetec Indústria Alimentícia S.A.Federal University of Minas Gerais; Faculdade de Ciências Médicas de Minas...CompletedCow's Milk Allergy
-
Laboratorios OrdesaSprim Advanced Life SciencesTerminatedCow's Milk AllergySpain, France
-
Federico II UniversityRecruiting
-
Société des Produits Nestlé (SPN)Completed
-
Assistance Publique - Hôpitaux de ParisESPCI ParisCompleted
-
Martini Hospital GroningenRecruitingCow Milk Allergy | Food AllergyNetherlands
-
University GhentActive, not recruitingCow Milk Allergy | Food AllergyBelgium
-
Federico II UniversityUnknown
Clinical Trials on Amino Acid-based Formula with high DHA and ARA
-
Mead Johnson NutritionCompleted
-
DSM Nutritional Products, Inc.SynteractHCRCompleted
-
Federico II UniversityCompleted
-
United PharmaceuticalsCompleted
-
Mead Johnson NutritionUniversity of Kansas; John Colombo, PhD, The University of KansasTerminatedMeasurement of Docosahexaenoic Acid Levels in Pre-school ChildrenUnited States
-
Nutricia ResearchTerminatedAllergy | Food AllergyUnited Kingdom, France, Germany
-
Federico II UniversityCompleted
-
Dr. Schär AG / SPACompleted